CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453728228
- Phone
- 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-20 | Sacks Natalie Director | Grant or award · Option to purchase Common Stock | +40,500 | 40,500 | ||
| 2025-02-20 | Haurwitz Rachel E. President and CEO | Grant or award | +136,750 | 295,450 | ||
| 2025-02-20 | Haurwitz Rachel E. President and CEO | Grant or award · Option to purchase Common Stock | +618,250 | 618,250 | ||
| 2025-02-20 | Braunstein Scott Director | Grant or award · Option to purchase Common Stock | +40,500 | 40,500 | ||
| 2025-02-20 | MCCLUNG BARBARA G Chief Legal Officer | Grant or award | +37,500 | 447,066 | ||
| 2025-02-20 | MCCLUNG BARBARA G Chief Legal Officer | Grant or award · Option to purchase Common Stock | +170,000 | 170,000 | ||
| 2025-02-20 | GUGGENHIME ANDREW Director | Grant or award · Option to purchase Common Stock | +40,500 | 40,500 | ||
| 2025-01-29 | Ryali Sriram Chief Financial Officer | Purchase | +17,360 | $1.42 | $25K | 17,360 |
| 2025-01-10 | Ryali Sriram Chief Financial Officer | Grant or award · Option to purchase Common Stock | +300,000 | 300,000 | ||
| 2024-11-20 | Fischesser Ryan VP of Finance and Controller | Grant or award | +25,000 | 118,854 | ||
| 2024-08-19 | Albertson Tina M. Chief Medical Officer | Grant or award · Option to purchase Common Stock | +300,000 | 300,000 | ||
| 2024-02-20 | O'Byrne Jason Chief Financial Officer | Grant or award | +33,000 | 59,224 | ||
| 2024-02-20 | O'Byrne Jason Chief Financial Officer | Grant or award · Option to purchase Common Stock | +153,000 | 153,000 | ||
| 2024-02-20 | MCCLUNG BARBARA G Chief Legal Officer | Grant or award | +33,000 | 409,566 | ||
| 2024-02-20 | MCCLUNG BARBARA G Chief Legal Officer | Grant or award · Option to purchase Common Stock | +153,000 | 153,000 | ||
| 2024-02-20 | Khan Ruhi Ahmad Chief Business Officer | Grant or award | +33,000 | 33,000 | ||
| 2024-02-20 | Khan Ruhi Ahmad Chief Business Officer | Grant or award · Option to purchase Common Stock | +153,000 | 153,000 | ||
| 2024-02-20 | Haurwitz Rachel E. President and CEO | Grant or award | +118,700 | 158,700 | ||
| 2024-02-20 | Haurwitz Rachel E. President and CEO | Grant or award · Option to purchase Common Stock | +546,950 | 546,950 | ||
| 2024-02-20 | Kanner Steven Chief Scientific Officer | Grant or award | +33,000 | 387,037 |
Page 3 of 9 · 177 trades